Hyperfine And Liminal Sciences Combine To Go Public Via SPAC Deal
Executive Summary
HealthCor Catalio Acquisition Corp, is acquiring Hyperfine, a developer of portable magnetic resonance imaging systems, and Liminal Sciences, which is focused on non-invasive brain monitoring. The new public company will also be called Hyperfine.
You may also be interested in...
Exec Chat: Pear Therapeutics’ CEO Charts Future For Digital Therapeutics Following SPAC Deal
Pear has commercialized FDA-cleared prescription digital therapeutics for substance abuse disorder, opioid use disorder and chronic insomnia and has 14 more in development. CEO Corey McCann explained Pear’s vision for how PDTs can transform health care.
Digital Health Start-Ups Continue To Be Attractive SPAC Targets
According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.
Surgical Robotics Company Vicarious Surgical To Merge With D8 SPAC In $1.1Bn Deal
Vicarious Surgical, whose medical robot received US FDA breakthrough designation, announced it will merge with D8 Holdings Corp. The deal is expected to garner up to $460m.